{
	"ASSERTIONS": {
		"id": 69, 
		"context": null, 
		"description": "T315I mutant ABL1 in p210 BCR-ABL cells resulted in retained high levels of phosphotyrosine at increasing concentrations of inhibitor STI-571, whereas wildtype appropriately received inhibition.", 
		"disease": {
			"name": "Chronic Myelogenous Leukemia", 
			"oncotree_code": "CML", 
			"oncotree_term": "Chronic Myelogenous Leukemia"
		}, 
		"therapy_name": "Imatinib", 
		"therapy_type": "Targeted therapy", 
		"clinical_significance": "resistance", 
		"predictive_implication": "Preclinical", 
		"feature_ids": [69], 
		"favorable_prognosis": null, 
		"created_on": "02/04/21", 
		"last_updated": "2019-06-13", 
		"submitted_by": "breardon@broadinstitute.org", 
		"validated": true, 
		"source_ids": [41], 
		"variant": {
			"id": 69, 
			"feature_type": "somatic_variant", 
			"gene": "ABL1", 
			"chromosome": "9", 
			"start_position": "133747580.0", 
			"end_position": "133747580.0", 
			"reference_allele": "C", 
			"alternate_allele": "T", 
			"cdna_change": "c.944C>T", 
			"protein_change": "p.T315I", 
			"variant_annotation": "Missense", 
			"exon": "5.0", 
			"rsid": null, 
			"feature": "ABL1 p.T315I (Missense)"
		}
	}, 
	"SOURCES": {
		"id": 41, 
		"type": "Journal", 
		"assertion_id": [69], 
		"doi": "10.1126/science.1062538", 
		"nct": "None", 
		"pmid": "11423618", 
		"url": "https://doi.org/10.1126/science.1062538", 
		"citation": "Gorre, Mercedes E., et al. \"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.\" Science 293.5531 (2001): 876-880."
	}, 
	"VARIANTS": {
		"id": 69, 
		"feature_type": "somatic_variant", 
		"gene": "ABL1", 
		"chromosome": "9", 
		"start_position": "133747580.0", 
		"end_position": "133747580.0", 
		"reference_allele": "C", 
		"alternate_allele": "T", 
		"cdna_change": "c.944C>T", 
		"protein_change": "p.T315I", 
		"variant_annotation": "Missense", 
		"exon": "5.0", 
		"rsid": null, 
		"feature": "ABL1 p.T315I (Missense)"
	}
}